Physicians' Academy for Cardiovascular Education

CV Risk Master Class

Middle East, Eastern Europe, African chapter - Dubai, May 24-25, 2013

May 28, 2013

An educational alliance to optimize management of cardiovascular disease

This Master Class program is a global initiative of the Physicians’ Academy for Cardiovascular Education(PACE) foundation with a particular focus on issues and opportunities in cardiovascular risk and lipid management in high risk patients.
This CV Risk Master Class are dynamic meetings with state of the art lectures, clinical debates, and practical workshops. Participants are part of an educational initiative that will provide support to clinicians in their daily clinical management of cardiovascular risk and diabetes. The program provides an optimal balance between updates in forefront science and clinical dialogue, with involvement of international and regional thought leaders.

The PACE International programme directors are:

  • Prof. John E. Deanfield, London
  • Prof. D. John Betteridge, London
  • Prof. John J.P. Kastelein, Amsterdam.

View all lectures via archived webcast 

May 24-25, 2013 - Dubai UAE

CV Risk Master Class - Middle East, Eastern Europe, African chapter

special passcode is required

Educational curriculum

Slide curriculum derived from lectures presented by faculty during the PACE Cardiovascular Risk Master Classes.The teaching slides are aimed to provide support to participants for use in regional educational programs. Slides will be frequently updated

Slides • 20-6-2013

Novel therapies for the prevention of atherosclerotic vascular disease

Teaching slides prepared and presented by Prof John Kastelein, AMC, Amsterdam, The Netherlands at the Cardiovascular Risk Master Classes in May 2013

Slides • 24-5-2013

Hypertension and cardiovascular disease

49 Teaching slides addressing hypertension and cardiovascular disease, blood pressure managent. .

Slides • 16-5-2013

Macrovascular disease in diabetes

Teaching slides addressing macrovascular disease in diabetes and lipid management  

Slides • 12-5-2013

Landmark statin trials across the spectrum of risk: Secondary stroke prevention

Teaching slides addressing secondary stroke prevention and statin therapy

Slides • 10-5-2013

Cardiovascular Risk: A global issue

Teaching slides addressing the global issues and epidemiology of cardiovascular disease and different risk factors

Slides • 10-5-2013

Landmark trials with statins

An overview of slides Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention

Slides • 10-5-2013

Cholesterol Lowering and CV Risk: Meta-analyses

An overview of different meta-analysis on cholesterol lowering and cardiovascular risk


The conference is sponsored by an unrestricted educational grant provided by Pfizer.

Share this page with your colleagues and friends: